1School of Pharmaceutical Sciences, University of Science Malaysia, Penang, Malaysia.
This study found the generic atenolol (Normaten FC) to be bioequivalent to the innovator product (Tenormin). Bioavailability parameters, including AUC0-infinity and Cmax, showed no significant differences, confirming therapeutic equivalence.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: